Nivolumab Biosimilar - Research Grade: APC

In stock

Only %1 left

SKU

ICH4009APC

Add to Compare

Be the first to review this product

$255.00

Skip to the end of the images gallery

Skip to the beginning of the images gallery

Add to Wish List

Nivolumab Biosimilar - Research Grade: APC

Unconjugated Product:

Nivolumab Biosimilar - Research Grade

Conjugate:

Allophycocyanin (APC)

Target:

PD-1

Clone:

n/a

Isotype:

IgG4 kappa

Other Names:

Receptor tyrosine-protein kinase erbB-2, MLN 19, HER2, HER2/neu

Host:

CHO Cells

Species Reactivity:

Human

Specificity:

Detects human ErbB2.

Background:

Nivolumab is a humanized IgG1 kappa monoclonal antibody that selectively binds with high affinity to the extracellular domain of the human epidermal growth factor receptor 2 protein, HER2. Nivolumab is produced by recombinant DNA technology in a mammalian cell (Chinese Hamster Ovary).

Concentration:

0.2 mg/ml

Formulation:

This Allophycocyanin (APC) conjugate is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4, 1% BSA and 0.09% sodium azide as a preservative.

Storage:

This Allophycocyanin (APC) conjugate is stable when stored at 2-8°C. Do not freeze.

Applications:

Flow Cytometry, IHC

Application Notes:

Red Laser (650 nm). Each investigator should determine their own optimal working dilution for specific applications.

Use: ichorbio's Nivolumab biosimilar is for research use only (RUO). Isotype Control:

Bulk Human IgG1 Isotype Control (IB1) [ICH2254]